Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS
Clinical trial NCT04181489 · UNKNOWN
Trial details
- NCT number
- NCT04181489
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2023-12-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.